Imagine regretting not snapping up BNB when it was still undervalued, watching it soar during past bull runs while others cashed in big. As the 2026 bull run loomsImagine regretting not snapping up BNB when it was still undervalued, watching it soar during past bull runs while others cashed in big. As the 2026 bull run looms

Missed Out on BNB Highs? BlockchainFX Is the Top Crypto To Buy Before The 2026 Bull Run

Imagine regretting not snapping up BNB when it was still undervalued, watching it soar during past bull runs while others cashed in big. As the 2026 bull run looms, investors are eyeing the next top crypto that could mirror or even surpass BNB’s trajectory. BlockchainFX emerges as that contender, positioning itself as the top crypto to buy for those seeking explosive gains before the market heats up.

BlockchainFX stands out in the crypto presale landscape with its innovative all-in-one decentralized platform, bridging DeFi and traditional finance like never before. As the best crypto presale right now, it offers access to stocks, forex, ETFs, and more, all while users retain full asset control. Already in beta and hailed as the “Best New Crypto Trading App of 2025,” BlockchainFX draws rave reviews from early adopters, making it the top crypto choice for the impending bull run.

BlockchainFX Breaks Presale Records Ahead of Launch

BlockchainFX has already raised $12.8 million from over 21,000 participants, nearing its $13 million soft cap with momentum building fast. At the current presale price of $0.031, this crypto presale signals massive early potential, especially with the launch price set at $0.05. The platform’s explosive growth, boasting thousands of daily users and millions in trading volume, underscores its real-world traction, helping investors build wealth through a thriving ecosystem that’s still in its infancy.

This growth translates to tangible benefits for holders, as higher user adoption drives demand for BFX tokens, potentially boosting value over time. Daily passive rewards add another layer, allowing stakers to earn BFX and USDT, with payouts up to $25,000 in USDT. Such features empower investors to generate steady income without active trading, turning holdings into a reliable revenue stream amid volatile markets.

BlockchainFX’s strong security foundation, backed by multiple third-party audits, full KYC, and verified smart contracts, ensures investor confidence. Its international trading license from the Anjouan Offshore Finance Authority sets it apart, providing regulatory clarity that most presales lack. With the app already live, this milestone paves the way for secure, global expansion.

Unlocking High ROI Potential

Consider investing $250 at $0.031 per BFX. That nets about 8,065 tokens, but using the limited-time bonus code APP50 adds 50% more, totaling around 12,097 tokens to celebrate the January 31 app launch. At the $0.05 launch price, this jumps to $605 value, but analysts predict $1 soon after, yielding $12,097a 48x return. Some forecasts even hit $5 post-launch, pushing that to $60,485, with 500x long-term potential turning $250 into over $100,000 as BlockchainFX scales like the next Binance.

On January 31, BlockchainFX launches V1.1 of the BlockFX.com trading app, rolling out in over 20 countries initially and expanding to 50-plus soon. Deposits and withdrawals support major cryptocurrencies, paired with 24/5 support, beginner videos, and free demos across 500+ assets, marking the start of a transformative era.

BNB’s Steady Path Amid Upgrades

BNB continues to hold firm in the market, trading around $900 to $950 in early 2026, with slight gains but struggling against key resistance levels like $937. Recent developments, including the Fermi hard fork upgrade that enhanced BNB Smart Chain’s throughput and finality, have provided some technical boosts, while Grayscale’s filing for a BNB ETF signals growing institutional interest.

The 34th quarterly token burn removed over 1.37 million BNB, aiming to reduce supply and support long-term value. However, market auction theory suggests potential weakness, with risks of rotation lower toward $800-$840 if resistance holds, reflecting BNB’s mature but range-bound phase amid broader crypto dynamics.

Seize the 2026 Bull Run Edge Now

As the 2026 bull run approaches, BlockchainFX stands as the best crypto presale, outshining established players like BNB with its groundbreaking features and untapped potential. This top crypto to buy offers a rare ground-floor entry, much like early BNB opportunities that created fortunes.

Urgency mounts with the January 31 app launch and presale price hikes imminent, investors should head to the BlockchainFX website, grab BFX using APP50 for that 50% bonus, and position for massive returns before it’s too late.

Find Out More Information Here

Website: https://blockchainfx.com/

X: https://x.com/BlockchainFXcom

Telegram Chat: https://t.me/blockchainfx_chat

The post Missed Out on BNB Highs? BlockchainFX Is the Top Crypto To Buy Before The 2026 Bull Run appeared first on Blockonomi.

Market Opportunity
Binance Coin Logo
Binance Coin Price(BNB)
$886.53
$886.53$886.53
+0.41%
USD
Binance Coin (BNB) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking

U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge

Here’s why Polygon price is at risk of a 25% plunge

Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26